APA (7th ed.) Citation

Hu, J., Lazar, A. J., Ingram, D., Wang, W., Zhang, W., Jia, Z., . . . Li, S. (2024). Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models. Journal for immunotherapy of cancer, 12(1), e006991. https://doi.org/10.1136/jitc-2023-006991

Chicago Style (17th ed.) Citation

Hu, Jiemiao, et al. "Cell Membrane-anchored and Tumor-targeted IL-12 T-cell Therapy Destroys Cancer-associated Fibroblasts and Disrupts Extracellular Matrix in Heterogenous Osteosarcoma Xenograft Models." Journal for Immunotherapy of Cancer 12, no. 1 (2024): e006991. https://doi.org/10.1136/jitc-2023-006991.

MLA (9th ed.) Citation

Hu, Jiemiao, et al. "Cell Membrane-anchored and Tumor-targeted IL-12 T-cell Therapy Destroys Cancer-associated Fibroblasts and Disrupts Extracellular Matrix in Heterogenous Osteosarcoma Xenograft Models." Journal for Immunotherapy of Cancer, vol. 12, no. 1, 2024, p. e006991, https://doi.org/10.1136/jitc-2023-006991.